RxDoctor Payments Data

Robert Witte, PA

Physician Assistant · Perrysburg, OHNPI 1700312162

Payments from drug & device makers

$4,639in general payments, 2019–2025

Across 212 payments — averaging $21.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$792
  • Merck$534
  • Novartis$478
  • E.r. Squibb & Sons, L.L.C.$404
  • Johnson & Johnson$385
  • Boehringer Ingelheim$232
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$4,625100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,639 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$79,349
Medicare patients
573
Services billed
1,008

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban511$534,237
XareltoRivaroxaban209$243,480
EntrestoSacubitril/Valsartan93$120,366
Repatha SureclickEvolocumab127$87,906
FarxigaDapagliflozin Propanediol47$54,791
JardianceEmpagliflozin44$42,142
MultaqDronedarone Hcl30$27,556
Repatha SyringeEvolocumab30$16,457
Praluent PenAlirocumab23$11,598
VascepaIcosapent Ethyl15$9,731
Metoprolol Succinate654$8,989
Icosapent Ethyl30$8,386
Atorvastatin Calcium380$4,325
Carvedilol410$3,782
Diltiazem 24hr Er (Cd)Diltiazem Hcl110$3,366

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$173$534,237511 claims
Johnson & JohnsonXarelto$385$243,480209 claims
NovartisEntresto$478$120,36693 claims
AstraZenecaFarxiga$792$54,79147 claims
Boehringer IngelheimJardiance$232$42,14244 claims
Sanofi-aventis U.S. LLCMultaq$26$27,55630 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Perrysburg

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →